銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Sakar Healthcare
SAKAR ?NSE

Sakar Healthcare

?803.607.70 (0.97%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
788.00
Today’s high
820.00
52 week low
311.00
52 week high
889.95
Open price
788.00
Previous close
795.90
Live volume
53,400
Lower circuit
723.25
Upper circuit
883.95

Fundamentals

Market Cap
?1,771Cr
ROE
9.40%
P/E Ratio(TTM)
58.09
EPS(TTM)
13.70
P/B Ratio
5.46
Dividend Yield
0.00%
Industry P/E
33.86
Book Value
145.82
Debt to Equity
0.17
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?71.27
+0.59%
Profit (Cr)
?11.02
+7.51%
020406080
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+41%
3Y CAGR+11%
Profit growthValue
1Y (TTM)+91%
3Y CAGR+5%

About

Sakar Healthcare is a prominent player within India's pharmaceutical industry, distinguished by its vertically integrated manufacturing capabilities, particularly in the field of oncology. The company's vision is to become a global healthcare organization built on the three pillars of people, partnership, and performance to deliver world-class healthcare solutions. Its mission focuses on strengthening core competencies to be the preferred choice for partnerships and exploring new market opportunities to expand its product range. The company operates state-of-the-art facilities to produce both Active Pharmaceutical Ingredients (APIs) and finished formulations, ensuring quality control across the value chain. Its four manufacturing plants create a wide range of dosage forms, which include oral liquids, solids, injectables, and dry powder inhalers. With a strong export focus supported by a global distribution network, the company successfully serves customers in over 60 countries around the world.;
CEO/MD
Mr. Sanjay S. Shah
Founded in
2004
NSE symbol
SAKAR

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
52.86%
Retail And Others
22.87%
Foreign Institutions
12.94%
Other Domestic Institutions
11.32%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
?8,433.50
-95.50 (1.12%)
L
    H
    21,286.25113.5124.39
    PfizerPFIZER
    ?4,533.70
    -5.60 (0.12%)
    L
      H
      20,766.7328.744.94
      ?1,448.40
      +17.80 (1.24%)
      L
        H
        19,822.7430.615.08
        ?786.90
        +4.80 (0.61%)
        L
          H
          19,386.3932.583.81
          Livesquawk ?
          Sakar Healthcare signs 40th deal with Zydus Lifesciences for oncology in GCC, emerging markets. Company filed 23 MAs in EU, gained 5 approvals, developed 21 APIs, and focuses on integration.
          Livesquawk ?
          Sakar Healthcare projects FY27 as a key year with stronger exports driving growth. Rising oncology volumes are expected to further support Sakar Healthcare's growth.
          Livesquawk ?
          Sakar Healthcare Q4 EBITDA rises to ?262M, up from ?157M YoY. EBITDA margin improves to 36.9% from 31.3% YoY.
          Livesquawk ?
          Sarkar Healthcare's Q3 revenue surged to 703M INR, up from 434M YoY. This marks a strong performance in the healthcare sector.
          Livesquawk ?
          Sakar Healthcare's Q3 EBITDA rose to 186M INR from 118M INR YoY. EBITDA margin slightly declined to 26.4% from 27.1% YoY.
          2026
          12
          May
          Annual Result
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          7
          Nov
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com